Novartis Acquires American Oncology Lab Genoptix For $470 Million
Amit Chowdhry | January 27, 2011 | 450 views | Add a CommentCategorized under Alcon, Genoptix, Novartis

Novartis is a Swiss pharmaceutical company that has acquired American oncology lab Genoptix for $470 million in cash. Novartis will be paying $25 for each share of Genoptix which is a 27% premium above the stock’s closing price of $19.76 on Friday.
